Dr. James M. Donahue is a thoracic surgeon and oncologist who is committed to improving outcomes for patients diagnosed with lung cancer, esophageal cancer, and other thoracic malignancies. As Section Chief of Thoracic Surgery and the James H. Estes Family Endowed Chair for Lung Cancer Research at the O’Neal Comprehensive Cancer Center at the University
Dr. David Sternberg is a board-certified surgeon, thoracic surgeon, and cardiothoracic surgeon who treats patients at the Karmanos Cancer Institute. Dr. Steinberg specializes in minimally invasive chest surgery and serves on the facility’s tumor board. His particular areas of clinical interest include lung cancer, esophageal cancer, and lung nodules, and he is skilled in robotic
Dr. Frank Baciewicz, Jr. is a thoracic and cardiothoracic surgeon at the Karmanos Cancer Institute and part of the Multidisciplinary Team of the Thoracic Oncology Program. He treats patients diagnosed with lung cancer and esophageal cancer, and his special clinical interests include minimally invasive robotic lung surgery, thoracoabdominal aneurysm surgery, ascending aorta, mediastinal tumors, descending
As a clinician at the Karmanos Cancer Institute in Detroit Michigan, Dr. Dipesh Uprety is actively involved in patient care within the Department of Thoracic Oncology. A specialist in lung cancer, thymoma and thymic carcinomas, and malignant pleural mesothelioma, he is particularly interested in how these challenging forms of cancer respond to treatment, and how
Dr. Tarik Hadid is a medical oncologist and hematologist who specializes in head and neck cancers and thoracic cancers. As a member of the Karmanos Cancer Institute’s Thoracic Oncology Program’s Multidisciplinary Team, he collaborates with other specialists to treat esophageal cancer, malignant pleural mesothelioma, lung cancer, and thymoma and thymic malignancies. This approach brings comprehensive expertise
Dr. Hirva Mamdani is a thoracic medical oncologist who specializes in the diagnosis and treatment of patients with malignant pleural mesothelioma, esophageal cancer, lung cancer, and other thoracic malignancies. She is the head of the Thoracic Oncology Multidisciplinary Team at Karmanos Cancer Institute in Detroit and is the Director of Lung Cancer Screening there. She is
Dr. Scott J. Swanson is an accomplished general and thoracic surgeon at the Dana-Farber Cancer Institute and Brigham & Women’s Hospital in Boston. He is the Director of Brigham & Women’s Minimally Invasive Thoracic Surgery Program at Brigham and Women’s Hospital and serves as Chief Surgical Officer and Thoracic Oncology Disease Center Leader for the
Dr. Pasi A. Jänne is a leading researcher and clinician in medical oncology and lung cancer. He is the Co-Leader of the Lung Cancer Program at Dana-Farber Harvard Cancer and sees patients at the Dana-Farber Institute Lowe Center for Thoracic Oncology. Dr. Jänne was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations.
Two of America’s most highly respected mesothelioma professionals have been named to new positions at the prestigious International Mesothelioma Interest Group (iMig). Joseph Friedberg, MD, FACS, and Melissa Culligan, RN, BSN, MSc, PhD candidate will bring the expertise that they deploy at Temple Health, the Lewis Katz School of Medicine at Temple University, and Fox
Dr. Bruce E. Johnson is a world-renowned lung cancer physician-scientist. As leader of the Lung Cancer Program for the Dana-Farber/Harvard Cancer Center in Boston, he oversees research that integrates the facilities’ patient populations and science and applies what is discovered to the treatment of patients with lung cancer, malignant mesothelioma, and other thoracic malignancies. Under